BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 136582)

  • 1. Huntington's disease: regional alteration in muscarinic cholinergic receptor binding in human brain.
    Wastek GJ; Stern LZ; Johnson PC; Yamamura HI
    Life Sci; 1976 Oct; 19(7):1033-9. PubMed ID: 136582
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in brain muscarinic cholinergic receptor binding and choline acetyltransferase activity in Huntington's disease.
    Wastek GJ; Johnson PC; Stern LZ; Yamamura HI
    Proc West Pharmacol Soc; 1976; 19():170-1. PubMed ID: 136659
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.
    Wastek GJ; Yamamura HI
    Mol Pharmacol; 1978 Sep; 14(5):768-80. PubMed ID: 152407
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain muscarinic cholinergic receptors in Huntington's disease.
    Lange KW; Javoy-Agid F; Agid Y; Jenner P; Marsden CD
    J Neurol; 1992 Feb; 239(2):103-4. PubMed ID: 1532417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea.
    Aquilonius SM; Eckernås SA; Sundwall A
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):669-77. PubMed ID: 125784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
    Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
    Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
    [No Abstract]   [Full Text] [Related]  

  • 7. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
    Ruberg M; Ploska A; Javoy-Agid F; Agid Y
    Brain Res; 1982 Jan; 232(1):129-39. PubMed ID: 7055689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic receptor binding in rat sympathetic ganglia is unaffected by denervation.
    Burt DR
    Brain Res; 1978 Mar; 143(3):573-9. PubMed ID: 647381
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurobiology and pharmacology of Huntington's disease.
    Enna SJ
    Life Sci; 1977 Jan; 20(2):205-11. PubMed ID: 190505
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding: implications for understanding tardive dyskinesia.
    Friedman E; Gianutsos G; Kuster J
    J Pharmacol Exp Ther; 1983 Jul; 226(1):7-12. PubMed ID: 6864552
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro studies on the effect of beta-carbolines on the activities of acetylcholinesterase and choline acetyltransferase and on the muscarinic receptor binding of the rat brain.
    Skup M; Oderfeld-Nowak B; Rommelspacher H
    J Neurochem; 1983 Jul; 41(1):62-8. PubMed ID: 6864229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subcortico-cortical cholinergic system is affected in Parkinson's disease.
    Dubois B; Ruberg M; Javoy-Agid F; Ploska A; Agid Y
    Brain Res; 1983 Dec; 288(1-2):213-8. PubMed ID: 6661617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denervation, supersensitivity and muscarinic receptors in the cat iris.
    Sachs DI; Kloog Y; Korczyn AD; Heron DS; Sokolovsky M
    Biochem Pharmacol; 1979 May; 28(9):1513-8. PubMed ID: 475861
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurotransmitter receptor alterations in Parkinson's disease.
    Reisine TD; Fields JZ; Yamamura HI
    Life Sci; 1977 Aug; 21(3):335-43. PubMed ID: 197361
    [No Abstract]   [Full Text] [Related]  

  • 16. Parasympathetic denervation decreases muscarinic receptor binding in rat parotid.
    Talamo BR; Adler SC; Burt DR
    Life Sci; 1979 Apr; 24(17):1573-80. PubMed ID: 481090
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of septal lesions to alter muscarinic cholinergic or benzodiazepine binding sites in hippocampus of rat brain.
    Overstreet DH; Speth RC; Hruska RE; Ehlert F; Dumont Y; Yamamura HI
    Brain Res; 1980 Aug; 195(1):203-7. PubMed ID: 6105004
    [No Abstract]   [Full Text] [Related]  

  • 18. The nucleus basalis in Huntington's disease.
    Clark AW; Parhad IM; Folstein SE; Whitehouse PJ; Hedreen JC; Price DL; Chase GA
    Neurology; 1983 Oct; 33(10):1262-7. PubMed ID: 6225032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute subcortical lesions modify cortical muscarinic receptors in human brain.
    Bracco L; Corradetti R; Amaducci L
    Neurosci Lett; 1982 Dec; 34(3):227-31. PubMed ID: 7162704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
    Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
    N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.